<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>贝壳社 | wechat-feeds</title><link>http://MzA5NTExNTIxNw.favicon.privacyhide.com/favicon.ico</link><description>贝壳社是国内领先的医疗健康创新创业服务平台，集聚政府、上市公司、投资机构和三甲医院等产业高端资源，提供一站式的全球生命健康人才项目引进、转化孵化和产业化等全产业链协同创新和赋能服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 03 Mar 2021 20:31:22 +0800</pubDate><image><url>http://MzA5NTExNTIxNw.favicon.privacyhide.com/favicon.ico</url><title>贝壳社 | wechat-feeds</title><link>http://MzA5NTExNTIxNw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>14款抗体递交上市申请，排队等待上市</title><link>https://mp.weixin.qq.com/s/124xoP1aCs4tlr87nQmbKw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwpF6ln6uw8KhEDIKNB0sdHaHo1R6ZTJlJ07SYIoRAx8ghXoEMuquZEbKdPQ5RvBdP9ElLGOyHnKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>正在接受FDA或EMA的监管审查]]></content:encoded><pubDate>Wed, 03 Mar 2021 17:31:24 +0800</pubDate></item><item><title>基药目录最新消息传来，986目标将逐步实现</title><link>https://mp.weixin.qq.com/s/sGyBUeJYcPbG4dgWZE4rJg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwpF6ln6uw8KhEDIKNB0sdHJyj0icJoibUZ0ib5XQLpHMgbmoWGa7MhEGUoiaRmdwwTQ4To9J2zGbVBPQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>今年内调整基药目录铁板钉钉]]></content:encoded><pubDate>Wed, 03 Mar 2021 17:31:24 +0800</pubDate></item><item><title>​降低疾病复发风险，安进双特异性抗体疗法3期临床结果发布；​国家卫健委：感控将成医学本科必修课 | 贝壳日报</title><link>https://mp.weixin.qq.com/s/VejYY_aRiPESkAFuOALErA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwpF6ln6uw8KhEDIKNB0sdHMhBeQBZjjX5kFrAd7z2XTOvfuWZIM6DZsex3GrjIpk3dTHQl7F3GHA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年3月3号医疗产业要闻]]></content:encoded><pubDate>Wed, 03 Mar 2021 17:31:24 +0800</pubDate></item><item><title>逼近100亿！2020年本土PD-1 销售额大爆发</title><link>https://mp.weixin.qq.com/s/FUv_PpyowKW0ijZW3-eMLQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekzCmibzLf6oPINm0EicicUick3mdaYcN960sEqf5w2zORWHicZ0d7qKssWS1H6SO8rhdfScRnBY4GsqiaVQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>百亿大关近在眼前。]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:11:21 +0800</pubDate></item><item><title>持续火爆！2月份国内药企8起License in /out 交易</title><link>https://mp.weixin.qq.com/s/9ZTRMN_9jf-TNVTibNGDTQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekzCmibzLf6oPINm0EicicUick3mONAj5ibicXrG1G5nsbQP3BeibVAy2kib7GTjbbHVa50e3aQLX3pfxJHxYQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>包含5起License in 及3起License out]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:11:21 +0800</pubDate></item><item><title>​降低疾病加重率56%，潜在“first-in-class”抗体疗法达到所有3期主要终点；​新版医保目录开始执行 | 贝壳日报</title><link>https://mp.weixin.qq.com/s/GoaQ-SEcsslBxc45UVDijQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekzCmibzLf6oPINm0EicicUick3m9MYf07rPbZWrpvL4tpuBuXOgEK2VZUZ9EYjv7U6nkS0tAIIDyehFfg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年3月2号医疗产业要闻]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:11:21 +0800</pubDate></item><item><title>国际罕见病日：贝康医疗宣布为1000个罕见病家庭提供大型公益资助活动，全球首款遗传病阻断试剂盒进入临床试验！</title><link>https://mp.weixin.qq.com/s/i_ChWZvRXOhigZ5yk2naWw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekxKxDu9cdDibCFFur0zmcNmVQhLcJ3nuzE0aC6Xqx2ESO7I6BPmLkRvnl1iaJTrBD2n1nTdFPa3susg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>让“罕见”成为“不见”。]]></content:encoded><pubDate>Mon, 01 Mar 2021 10:30:50 +0800</pubDate></item><item><title>CAR-T里程碑专利及全球概况</title><link>https://mp.weixin.qq.com/s/2zDA9Oa5pYkpvE-duS3anQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwicOVOc5SdF3ib5cTKsyYgRLkTlQufV9reXbvkXcyiaWhMoetfCtT2ZTQB0WamamfcM59vw63eGnmhw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T专利在过去十年中表现出急剧的增长]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:39:25 +0800</pubDate></item><item><title>恒瑞榜首！A股上市药企研发投入Top100来了！</title><link>https://mp.weixin.qq.com/s/aBsBaWeClQGnT-Urz-3F_Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwicOVOc5SdF3ib5cTKsyYgRLjwoVZGQBWJYS5N6NWDvxOsXy0hCViagfFkxicfZSN45XUc1ZYAI65ic3g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>A股药企top10（含医疗器械）营收2689.51亿元，研发投入123亿元，平均每个药企投入12.3亿元，占营收比例4.58%左右。]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:21:56 +0800</pubDate></item><item><title>赛诺菲的基因疗法布局</title><link>https://mp.weixin.qq.com/s/R4EJsxgvE7uLMjQzUOTTFg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwicOVOc5SdF3ib5cTKsyYgRLD48mEo2YXW5sicfiaBAT4BMhUL2sC9ZLBHyhR49SkDR1Yrz1ClcUcKfw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>赛诺菲开始寻求新技术完善其基因疗法。]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:21:56 +0800</pubDate></item><item><title>多款新冠疫苗已在中国获批！有灭活疫苗、腺病毒疫苗、mRNA疫苗等</title><link>https://mp.weixin.qq.com/s/-MWceeoMJfOJ2loGSE9b-Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwicOVOc5SdF3ib5cTKsyYgRLBnic2wG4B1fmucR6re4oAxicdQFUEWPyJdTLsiaRQEIRChQISIWIcOwxQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>随着多款新冠疫苗相继获批，人类在抗击疫情方面有望迎来新的局面。]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:21:56 +0800</pubDate></item><item><title>​FDA今日加速批准DMD疗法上市；​医保局：力争年底全国门诊费用跨省直接结算 | 贝壳日报</title><link>https://mp.weixin.qq.com/s/4S5LfbUwuuHUs3050UG41g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekwicOVOc5SdF3ib5cTKsyYgRLRGWpel212NLYeZ1NpBLIckFwwY5icrrib8Fn7YsL4gEyrFam3roM2Fxw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年2月26号医疗产业要闻]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:21:56 +0800</pubDate></item><item><title>难难难！产品上市一延再延，基因疗法“老鸟”坎坷不断</title><link>https://mp.weixin.qq.com/s/ezm9YNGWm82nRz4f1x0VHQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekx22oGhb8OjyaF1qljYaCUMwsThFdwAhM7I0LDEzAmm25YnP6ic8k8LhLZVwsv3cI1WueZpYiazUbSQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>是绝境，还是仅路遇“颠簸”？]]></content:encoded><pubDate>Thu, 25 Feb 2021 17:32:32 +0800</pubDate></item><item><title>TG-Bio 2021第二届免疫治疗技术大会</title><link>https://mp.weixin.qq.com/s/XmAwtS1oifrqVqhyDHxDiQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekxgibKf8ib3NCQbGa4B8sykyVQcYVoAiaUwlWJJ60okGeZaFzjaMic1hsIRPM4KDm24DrHnlrqomZZUbA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>等你来！！！]]></content:encoded><pubDate>Thu, 25 Feb 2021 17:32:32 +0800</pubDate></item><item><title>​针对新冠突变病毒，Moderna改良疫苗即将开始临床试验；​圣诺生物左西孟旦注射液挂网价降至1625元/支 | 贝壳日报</title><link>https://mp.weixin.qq.com/s/O28t5UTPtSH1WsbKEbk45w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekxgibKf8ib3NCQbGa4B8sykyVr7xuXXUZ2M6IU6FhdeMdXmcKTNo8FktU1U4tUcZWiajSOQM074a577g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年2月25号医疗产业要闻]]></content:encoded><pubDate>Thu, 25 Feb 2021 17:32:32 +0800</pubDate></item><item><title>澳大利亚百名患者对无创PGT(又称niPGT)发起集体医疗诉讼</title><link>https://mp.weixin.qq.com/s/MoLuAOQLRrVarAYuY0-wlg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekx22oGhb8OjyaF1qljYaCUMMRyCFaCVvflQGiclExE8OAG3mTKmlAVLezhAVDPxGPNRicAUyVg1uOJA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>据悉，截止被叫停之前，该技术已被使用共达13000次。]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:07:35 +0800</pubDate></item><item><title>​保护效力达96-99%，辉瑞脑炎疫苗获FDA优先审评资格；​2021中央一号文件发布 村级医疗迎来大转变 | 贝壳日报</title><link>https://mp.weixin.qq.com/s/FJeSGWU3fFKfYXXL8fHVFg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekx22oGhb8OjyaF1qljYaCUMCNzKmte9lhYMVWPHbTYJblTbRsvbn3hpn9W1HhINf2N2FrHjTlfZKg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年2月24号医疗产业要闻]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:07:35 +0800</pubDate></item><item><title>首发 | 重磅！赛雷纳（中国）医疗科技屡获资本青睐，完成B+轮融资</title><link>https://mp.weixin.qq.com/s/LqN6zgMYCUclCcqu8dQqCA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekxiaanMgbU1h3loGcufGLnqF8sI2SAxpymATPtOqXjaWPPovrgEFc3VOGjHNialPGVhaoghVwBesricw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>此次融资由沛坤基金领投、厦门硅谷火炬基金跟投]]></content:encoded><pubDate>Tue, 23 Feb 2021 17:15:05 +0800</pubDate></item><item><title>首发 | 由泰格医药、泰煜投资联合领投，CDMO国际新锐百因诺生物完成近亿元Pre-A轮融资</title><link>https://mp.weixin.qq.com/s/Sbwo36tedvE6dvMR3Tfv8Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekxiaanMgbU1h3loGcufGLnqFKItcTvemNGaIddgxNgcqFLmXIGtEK0rLN7mRt1oQVxTIYM5PEmyLlQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本轮融资主要用于百因诺生物在苏州太仓的研发和生产基地建设、人才引进等方面。]]></content:encoded><pubDate>Tue, 23 Feb 2021 17:15:05 +0800</pubDate></item><item><title>​ 一线治疗非小细胞肺癌，赛诺菲/再生元PD-1抑制剂获FDA批准；3部委联合发布医学科研新规 | 贝壳日报</title><link>https://mp.weixin.qq.com/s/0yGu7ZyCgDAPNSD5z_acKw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Q9yBLRdqekyYC4fQbict83Fe8nmWMHHVd9xnQplTuE7QqX81bVQK2Xxys3tjECulxKdhwicq8dlrg0NMCCEy1fmQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年2月23号医疗产业要闻]]></content:encoded><pubDate>Tue, 23 Feb 2021 17:15:05 +0800</pubDate></item></channel></rss>